NCT04436393View on ClinicalTrials.gov

Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

March 17, 2022

Study Completion Date

March 17, 2022

Conditions
Advanced Breast Cancer
Interventions
DIAGNOSTIC_TEST

Guardant360 test

tumor cfDNA testing

Trial Locations (1)

94063

Guardant Health, Redwood City

Sponsors
All Listed Sponsors
lead

Guardant Health, Inc.

INDUSTRY